Corvus Pharmaceuticals, Inc. Major Shareholders & Ownership History
Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
---|---|---|---|---|---|
ORBIMED ADVISORS LLC | 02/14/2025 | 6.94 M | $37.15 M | 0.00% | 10.41% |
SAMLYN CAPITAL, LLC | 02/14/2025 | 6.67 M | $35.67 M | 47.17% | 10.00% |
ADAMS STREET PARTNERS LLC | 02/14/2025 | 3.28 M | $17.52 M | 0.00% | 4.91% |
POINT72 ASSET MANAGEMENT, L.P. | 02/14/2025 | 3.03 M | $16.21 M | -45.53% | 4.54% |
RTW INVESTMENTS, LP | 02/14/2025 | 2.68 M | $14.34 M | 100.00% | 4.02% |
VANGUARD GROUP INC | 02/11/2025 | 2.45 M | $13.13 M | 1.40% | 3.68% |
VIVO CAPITAL, LLC | 02/13/2025 | 2.23 M | $11.95 M | 49.24% | 3.35% |
FORESITE CAPITAL MANAGEMENT VI LLC | 02/14/2025 | 1.58 M | $8.46 M | 100.00% | 2.37% |
BLACKROCK FUNDING, INC. /DE | 02/07/2025 | 1.07 M | $5.74 M | 77.68% | 1.61% |
SUSQUEHANNA INTERNATIONAL GROUP, LLP | 02/14/2025 | 1.02 M | $5.43 M | 363.59% | 1.52% |
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 02/14/2025 | 1.00 M | $5.35 M | 100.00% | 1.50% |
IKARIAN CAPITAL, LLC | 02/14/2025 | 754,400 | $4.04 M | 245.58% | 1.13% |
CAPTION MANAGEMENT, LLC | 02/14/2025 | 631,200 | $3.38 M | 100.00% | 0.95% |
GOLDMAN SACHS GROUP INC | 02/11/2025 | 584,546 | $3.13 M | 55.41% | 0.88% |
GEODE CAPITAL MANAGEMENT, LLC | 02/12/2025 | 566,863 | $3.03 M | 0.68% | 0.85% |
SPHERA FUNDS MANAGEMENT LTD. | 02/14/2025 | 500,491 | $2.68 M | 100.00% | 0.75% |
GOLDMAN SACHS GROUP INC | 02/11/2025 | 500,000 | $2.68 M | 0.00% | 0.75% |
IKARIAN CAPITAL, LLC | 02/14/2025 | 500,000 | $2.68 M | 100.00% | 0.75% |
QUBE RESEARCH & TECHNOLOGIES LTD | 02/14/2025 | 450,050 | $2.41 M | 253.45% | 0.67% |
RENAISSANCE TECHNOLOGIES LLC | 02/13/2025 | 390,688 | $2.09 M | 1.06% | 0.59% |
BOOTHBAY FUND MANAGEMENT, LLC | 02/14/2025 | 218,600 | $1.17 M | 242.63% | 0.33% |
STATE STREET CORP | 02/14/2025 | 205,538 | $1.10 M | 15.31% | 0.31% |
MILLENNIUM MANAGEMENT LLC | 02/14/2025 | 181,200 | $969,420 | 18.59% | 0.27% |
JANE STREET GROUP, LLC | 02/14/2025 | 162,300 | $868,305 | 100.00% | 0.24% |
SUSQUEHANNA INTERNATIONAL GROUP, LLP | 02/14/2025 | 159,200 | $851,720 | 323.40% | 0.24% |
MILLENNIUM MANAGEMENT LLC | 02/14/2025 | 154,901 | $828,720 | -50.24% | 0.23% |
LMR PARTNERS LLP | 02/14/2025 | 152,500 | $815,875 | 100.00% | 0.23% |
BOOTHBAY FUND MANAGEMENT, LLC | 02/14/2025 | 144,300 | $772,005 | 100.00% | 0.22% |
SIMPLEX TRADING, LLC | 02/11/2025 | 139,933 | $748,000 | 2,367.95% | 0.21% |
SCHONFELD STRATEGIC ADVISORS LLC | 02/14/2025 | 129,076 | $690,556 | -61.05% | 0.19% |
SUSQUEHANNA INTERNATIONAL GROUP, LLP | 02/14/2025 | 124,300 | $665,005 | 179.96% | 0.19% |
ENTRYPOINT CAPITAL, LLC | 02/11/2025 | 116,645 | $624,051 | 100.00% | 0.17% |
JANE STREET GROUP, LLC | 02/14/2025 | 114,952 | $614,993 | 128.89% | 0.17% |
RAYMOND JAMES FINANCIAL INC | 02/13/2025 | 108,989 | $583,092 | 100.00% | 0.16% |
BARCLAYS PLC | 02/13/2025 | 106,019 | $567,000 | 100.00% | 0.16% |
SQUAREPOINT OPS LLC | 02/14/2025 | 98,144 | $525,070 | 712.45% | 0.15% |
ENGINEERS GATE MANAGER LP | 02/14/2025 | 84,612 | $452,674 | 100.00% | 0.13% |
TOWERVIEW LLC | 02/05/2025 | 77,500 | $414,625 | -34.04% | 0.12% |
OMERS ADMINISTRATION CORP | 02/14/2025 | 75,500 | $403,925 | 100.00% | 0.11% |
ACUTA CAPITAL PARTNERS, LLC | 02/14/2025 | 74,307 | $397,542 | 100.00% | 0.11% |
JANE STREET GROUP, LLC | 02/14/2025 | 69,200 | $370,220 | 100.00% | 0.10% |
JACKSON SQUARE CAPITAL, LLC | 01/15/2025 | 63,773 | $341,186 | 0.00% | 0.10% |
XTX TOPCO LTD | 02/13/2025 | 57,213 | $306,090 | 306.17% | 0.09% |
GROUP ONE TRADING, L.P. | 02/14/2025 | 52,768 | $282,309 | 849.06% | 0.08% |
UBS GROUP AG | 02/14/2025 | 52,109 | $278,783 | 232.31% | 0.08% |
HIKARI POWER LTD | 02/04/2025 | 49,959 | $267,000 | 0.00% | 0.07% |
BALYASNY ASSET MANAGEMENT L.P. | 02/14/2025 | 48,335 | $258,592 | 100.00% | 0.07% |
CITIGROUP INC | 02/12/2025 | 48,222 | $257,988 | -60.75% | 0.07% |
AMERICAN CENTURY COMPANIES INC | 02/11/2025 | 43,774 | $234,191 | 140.41% | 0.07% |
BRIDGEWAY CAPITAL MANAGEMENT, LLC | 02/14/2025 | 41,300 | $220,955 | -67.56% | 0.06% |
Corvus Pharmaceuticals, Inc. institutional Ownership - FAQ's
During the previous two years, 109 institutional investors and hedge funds held shares of Corvus Pharmaceuticals, Inc.. The most heavily invested institutionals were:
ORBIMED ADVISORS LLC: 6.94 M
SAMLYN CAPITAL, LLC: 6.67 M
ADAMS STREET PARTNERS LLC: 3.28 M
Point72 Asset Management, L.P.: 3.03 M
RTW INVESTMENTS, LP: 2.68 M
VANGUARD GROUP INC: 2.45 M
56.48% of Corvus Pharmaceuticals, Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 40.33 M shares in the last 24 months. This purchase volume represents approximately $243.20 M in transactions.